Why These 15 Large-Cap Stocks Are Plunging So Far In 2025

Page 12 of 14

3. Illumina Inc (NASDAQ:ILMN)

Number of Hedge Fund Holders In Q4 2024: 61

Illumina Inc (NASDAQ:ILMN) is a biotech company.

The stock is down significantly so far in 2025 as Illumina was placed on China’s “Unreliable Entities List.” This could make it a potential loser if sanctions and trade restrictions keep getting tougher. China accounts for approximately 7% of Illumina’s revenue.

Moreover, Illumina’s Q4 results slightly exceeded analyst expectations, but this wasn’t enough to offset its weak guidance for this year.

Management projected revenue growth of low single digits and non-GAAP EPS between $4.50-$4.65. Illumina’s fiscal year 2024 revenue decreased by 2% year-over-year to $4.33 billion.

The consensus price target of $149.25 implies 74.17% upside.

ILMN stock is down 35.88% year-to-date.

Page 12 of 14